Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$587 Sell
15
-9
-38% -$334 ﹤0.01% 1199
2026
Q1
$961 Sell
24
-15
-38% -$710 ﹤0.01% 1056
2025
Q4
$1.75K Sell
39
-20
-34% -$925 ﹤0.01% 1011
2025
Q3
$2.64K Sell
59
-15
-20% -$718 ﹤0.01% 886
2025
Q2
$3.56K Buy
74
+69
+1,380% +$3K ﹤0.01% 986
2025
Q1
$201 Buy
+5
New +$210 ﹤0.01% 1648

Other funds holding QGEN

SouthState Corp's QGEN Position: Q2 2026 in Review

SouthState Corp reduced its Qiagen (QGEN) stake by 38% in Q2 2026, selling an estimated $334 and leaving 15 shares worth $587. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

SouthState Corp first reported a position in QGEN in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.56K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • SouthState Corp held 15 shares of Qiagen worth $587 as of Q2 2026.
  • SouthState Corp sold 9 Qiagen shares in Q2 2026, an estimated $334.
  • Qiagen made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1199 holding.
  • SouthState Corp first reported a position in Qiagen in Q1 2025 and has held it in 6 quarters since.
  • SouthState Corp's Qiagen position peaked at $3.56K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.